Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth's Geisel School of Medicine and published in the journal Vaccine.
from The Medical News https://ift.tt/34e6iDe
from The Medical News https://ift.tt/34e6iDe
Comments
Post a Comment